NCT06802185View on ClinicalTrials.gov

A Bioequivalence Study of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) Versus Advil Dual Action Caplets (125 mg/250 mg) and Bioavailability Assessment of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) and Advil Liqui-Gels (200 mg) in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

April 12, 2025

Study Completion Date

April 12, 2025

Conditions
Pain
Interventions
DRUG

ADA Liquid Filled Capsules (Test Product)

ADA liquid filled capsules containing 125 mg ibuprofen and 250 mg acetaminophen.

DRUG

ADA Caplets (Reference Product)

ADA Caplets containing 125 mg ibuprofen and 250 mg acetaminophen.

DRUG

Advil Liqui-gels (Reference Product)

Advil Liqui-gels containing 200 mg ibuprofen.

Trial Locations (1)

53095

Spaulding Clinical, West Bend

All Listed Sponsors
lead

HALEON

INDUSTRY

NCT06802185 - A Bioequivalence Study of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) Versus Advil Dual Action Caplets (125 mg/250 mg) and Bioavailability Assessment of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) and Advil Liqui-Gels (200 mg) in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter